New Hyperlipidemias Study Findings Recently Were Published by Researchers at Jilin Agricultural University (Pleurotus abieticola Polysaccharide Alleviates Hyperlipidemia Symptoms via Inhibition of Nuclear Factor-kB/Signal Transducer and...).

A recent study conducted by researchers at Jilin Agricultural University in China has found that Pleurotus abieticola polysaccharide (PAPS1), derived from an edible fungus, has potential therapeutic effects in reducing hyperlipidemia symptoms. Hyperlipidemia is a metabolic syndrome associated with obesity and poses a significant threat to human health. The study showed that PAPS1 administration in mice with high-fat diet-induced hyperlipidemia resulted in reduced body weight gain, improved blood glucose and lipid levels, reduced fat accumulation, and mitigated liver damage. PAPS1 also demonstrated anti-inflammatory and antioxidant effects by inhibiting the NF-kB/STAT3 signaling pathway. These findings suggest that PAPS1 could be an effective therapeutic agent for reducing lipid levels through its anti-inflammatory properties. [Extracted from the article]